These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease models. Joachimiak P; Ciesiołka A; Kozłowska E; Świtoński PM; Figura G; Ciołak A; Adamek G; Surdyka M; Kalinowska-Pośka Ż; Figiel M; Caron NS; Hayden MR; Fiszer A BMC Biol; 2023 Feb; 21(1):17. PubMed ID: 36726088 [TBL] [Abstract][Full Text] [Related]
10. Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients. Pfister EL; Kennington L; Straubhaar J; Wagh S; Liu W; DiFiglia M; Landwehrmeyer B; Vonsattel JP; Zamore PD; Aronin N Curr Biol; 2009 May; 19(9):774-8. PubMed ID: 19361997 [TBL] [Abstract][Full Text] [Related]
11. Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. Hu J; Matsui M; Gagnon KT; Schwartz JC; Gabillet S; Arar K; Wu J; Bezprozvanny I; Corey DR Nat Biotechnol; 2009 May; 27(5):478-84. PubMed ID: 19412185 [TBL] [Abstract][Full Text] [Related]
12. ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy. Liu J; Yu D; Aiba Y; Pendergraff H; Swayze EE; Lima WF; Hu J; Prakash TP; Corey DR Nucleic Acids Res; 2013 Nov; 41(20):9570-83. PubMed ID: 23935115 [TBL] [Abstract][Full Text] [Related]
13. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon. Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897 [TBL] [Abstract][Full Text] [Related]
14. Allele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA. Hu J; Matsui M; Corey DR Ann N Y Acad Sci; 2009 Sep; 1175():24-31. PubMed ID: 19796074 [TBL] [Abstract][Full Text] [Related]
17. Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs. Hu J; Liu J; Yu D; Aiba Y; Lee S; Pendergraff H; Boubaker J; Artates JW; Lagier-Tourenne C; Lima WF; Swayze EE; Prakash TP; Corey DR Nucleic Acid Ther; 2014 Jun; 24(3):199-209. PubMed ID: 24694346 [TBL] [Abstract][Full Text] [Related]
18. Artificial miRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation inhibition of mutant transcripts. Ciesiolka A; Stroynowska-Czerwinska A; Joachimiak P; Ciolak A; Kozlowska E; Michalak M; Dabrowska M; Olejniczak M; Raczynska KD; Zielinska D; Wozna-Wysocka M; Krzyzosiak WJ; Fiszer A Cell Mol Life Sci; 2021 Feb; 78(4):1577-1596. PubMed ID: 32696070 [TBL] [Abstract][Full Text] [Related]
19. Polyglutamine (PolyQ) diseases: genetics to treatments. Fan HC; Ho LI; Chi CS; Chen SJ; Peng GS; Chan TM; Lin SZ; Harn HJ Cell Transplant; 2014; 23(4-5):441-58. PubMed ID: 24816443 [TBL] [Abstract][Full Text] [Related]
20. Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism. Hu J; Liu J; Corey DR Chem Biol; 2010 Nov; 17(11):1183-8. PubMed ID: 21095568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]